Inogen | INGN - Gross Profit On Sales


Inogen reported $41.34M in Gross Profit on Sales for its fiscal quarter ending in September of 2024.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Accuray USD 41.89M 7.42M Dec/2024
AngioDynamics USD 38.86M 1.05M Feb/2025
Artivion USD 61.01M 2.32M Sep/2024
AtriCure USD 105.34M 4M Dec/2025
Baxter International USD 577M 373M Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Boston Scientific USD 3.68B 136M Dec/2025
Chart Industries USD 375.2M 11.7M Sep/2025
Cooper Companies USD 650.8M 62.6M Sep/2025
Dexcom USD 792.7M 61.3M Dec/2025
Edwards Lifesciences USD 1.23B 18.7M Dec/2025
Globus Medical USD 535.95M 49.28M Dec/2025
Inogen USD 41.34M 1.39M Sep/2024
Insulet USD 568.6M 58.5M Dec/2025
Masimo USD 247.3M 16.7M Dec/2025
Medtronic USD 5.41B 27M Dec/2025
Orthofix International USD 545.88M 410.83M Dec/2024
Philips EUR 2.29B 377M Dec/2025
ResMed USD 878.72M 57.9M Dec/2025
Steris USD 655.5M 9.6M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.45M 144.2M Dec/2025
X T L Biopharmaceuticals USD -43K 89K Dec/2024
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025